학술논문
Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis
Document Type
Article
Author
Source
In Multiple Sclerosis and Related Disorders November 2016 10:204-212
Subject
Language
ISSN
2211-0348